STAAR Surgical (NASDAQ:STAA) Earns "Sell (D)" Rating from Weiss Ratings

STAAR Surgical (NASDAQ:STAA - Get Free Report)'s stock had its "sell (d)" rating reissued by equities research analysts at Weiss Ratings in a report released on Wednesday,Weiss Ratings reports.Get STAAR Surgical alerts:Top 4 Stocks With Notable Insider BuyingSTAA has been the topic of a number of other reports. Piper Sandler upgraded STAAR Surgical to a "hold" rating in a report on Wednesday, June 18th. Canaccord Genuity Group raised their price objective on STAAR Surgical from $20.00 to $28.00 and gave the company a "hold" rating in a research note on Wednesday, August 6th. Mizuho raised their price objective on STAAR Surgical from $17.00 to $18.00 and gave the company a "neutral" rating in a research note on Wednesday, July 16th. Finally, Stifel Nicolaus set a $28.00 price objective on STAAR Surgical and gave the company a "hold" rating in a research note on Thursday, August 7th. Ten research analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, STAAR Surgical presently has a consensus rating of "Reduce" and an average target price of $20.67.View Our Latest Analysis on STAAR SurgicalSTAAR Surgical Stock Down 0.8%Star Surgical Shines as U.S. Outlook Improves for 2024 Shares of STAA opened at $26.50 on Wednesday. STAAR Surgical has a 12-month low of $13.50 and a 12-month high of $33.28. The business's fifty day moving average is $26.83 and its 200 day moving average is $20.79. The stock has a market cap of $1.31 billion, a P/E ratio of -13.73 and a beta of 0.82. Institutional Investors Weigh In On STAAR SurgicalLarge investors have recently added to or reduced their stakes in the company. CWM LLC increased its holdings in STAAR Surgical by 74.1% in the 2nd quarter. CWM LLC now owns 1,563 shares of the medical instruments supplier's stock worth $26,000 after acquiring an additional 665 shares during the last quarter. US Bancorp DE increased its holdings in STAAR Surgical by 1,693.0% in the 1st quarter. US Bancorp DE now owns 2,044 shares of the medical instruments supplier's stock worth $36,000 after acquiring an additional 1,930 shares during the last quarter. Brooklyn Investment Group increased its holdings in STAAR Surgical by 1,564.0% in the 1st quarter. Brooklyn Investment Group now owns 2,679 shares of the medical instruments supplier's stock worth $47,000 after acquiring an additional 2,518 shares during the last quarter. GAMMA Investing LLC increased its holdings in STAAR Surgical by 61.4% in the 3rd quarter. GAMMA Investing LLC now owns 1,856 shares of the medical instruments supplier's stock worth $50,000 after acquiring an additional 706 shares during the last quarter. Finally, PNC Financial Services Group Inc. increased its holdings in STAAR Surgical by 691.0% in the 2nd quarter. PNC Financial Services Group Inc. now owns 3,607 shares of the medical instruments supplier's stock worth $61,000 after acquiring an additional 3,151 shares during the last quarter. Hedge funds and other institutional investors own 96.70% of the company's stock. About STAAR Surgical (Get Free Report)STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.Read MoreFive stocks we like better than STAAR SurgicalWhat Are Dividends? Buy the Best Dividend StocksLowe’s vs. Home Depot: Which Benefits More From Lower Rates?What is the Shanghai Stock Exchange Composite Index?These 5 Beaten-Down Tech Stocks Could Catch Fire NextWhat to Know About Investing in Penny StocksFalcon Flex Drives Growth as CrowdStrike Bets on AI SecurityThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in STAAR Surgical Right Now?Before you consider STAAR Surgical, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and STAAR Surgical wasn't on the list.While STAAR Surgical currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here